SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,073.07 |
| Enterprise Value ($M) | 1,186.17 |
| Book Value ($M) | 57.62 |
| Book Value / Share | 1.62 |
| Price / Book | 18.62 |
| NCAV ($M) | -146.86 |
| NCAV / Share | -4.12 |
| Price / NCAV | -7.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.13 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.47 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.44 |
| Current Ratio | 1.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 147.06 |
| Assets | 351.54 |
| Liabilities | 293.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Kaufman Daniel Louis | 4.75 | -11.69 | |
| 13G/A | Ophir Asset Management Pty Ltd | 2.80 | -59.64 | |
| 13G | Vanguard Group Inc | 5.15 | ||
| 13G/A | Opaleye Management Inc. | 10.88 | 1.19 | |
| 13G | BlackRock, Inc. | 6.30 | 436.54 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 76,136 | 483,764 | 15.74 | |
| 34,782 | 150,906 | 23.05 | |
| 51,130 | 224,725 | 22.75 | |
| 64,192 | 267,489 | 24.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GHRS – GH Research PLC | HCWB – HCW Biologics Inc. |
| HRMY – Harmony Biosciences Holdings, Inc. | IKNA – Ikena Oncology, Inc. |
| IMRX – Immuneering Corporation |
Financial data and stock pages provided by
Fintel.io